|
|
Health Care PRESS ROOM |
|
|
|
Have-nots lose on Avastin ruling
Submitted by Sally C. Pipes on 12.23.2010
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA's decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin for them this year.
The Fatal Move From The FDA
Submitted by Sally C. Pipes on 12.16.2010
On Dec. 17 the Food and Drug Administration is expected to take the radical step of revoking approval for an advanced drug in the treatment of one of the country's most deadly diseases.
U.S. competitive without medical monopoly
Submitted by John R. Graham on 12.10.2010
The November election made a bull's-eye out of Obamacare, which some Republicans want to repeal. Obamacare is a worthy target because it is a significant lurch toward so-called "universal" health care.
FDA's Decision On Avastin Will Set the Standard
Submitted by Sally C. Pipes on 12.8.2010
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform.
Pipes to speak on economic impact of health care bill
Submitted on 12.4.2010
COTATI – The Economic Prosperity Institute will host an event titled, “The Truth about ObamaCare” at Sonoma State University on Dec. 9 at 11:45 a.m. Sally Pipes, president and CEO of the Pacific Research Institute, will discuss the research and insights in her book of the same title.
Repeal Amendment deserves debate
Submitted by Brian Calle on 12.3.2010
When the new Congress — including many representatives and senators purporting to be ideological citizen-activists inspired by the Tea Party — takes office Jan. 2, it is likely that perhaps the most unsettled issue in the nation’s history will be showcased: the debate over states' rights. This time, though, it may take the form of a proposed constitutional amendment to empower states against federal overreaches.
|
|
|
 |
